Vasodilator therapy for primary pulmonary hypertension in children.
about
Drug treatment of pulmonary hypertension in childrenPharmacotherapy for pulmonary hypertensionPulmonary arterial hypertension: a comparison between children and adultsPulmonary arterial hypertension associated with congenital heart disease and Eisenmenger syndrome: current practice in pediatricsLong term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusionPulmonary Hypertension in Children.Persistent Challenges in Pediatric Pulmonary Hypertension.Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registryAssessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry.Use of Amplatzer fenestrated atrial septal defect device in a child with familial pulmonary hypertension.Pediatric pulmonary arterial hypertension.Safety of cardiac catheterization at a center specializing in the care of patients with pulmonary arterial hypertensionSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension in children.Current management of patients with pulmonary hypertension and right ventricular insufficiency.Novel therapeutics for the treatment of paediatric pulmonary arterial hypertension.Reducing TRPC1 Expression through Liposome-Mediated siRNA Delivery Markedly Attenuates Hypoxia-Induced Pulmonary Arterial Hypertension in a Murine Model.Prostacyclin in the intensive care setting.Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertensionMedical therapy for pediatric pulmonary arterial hypertensionWeaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.Non-congenital heart disease associated pediatric pulmonary arterial hypertensionSevere paediatric pulmonary hypertension: new management strategiesTreatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.Recommendations on the management of pulmonary hypertension in clinical practice.Acute endothelin A receptor antagonism improves pulmonary and systemic haemodynamics in patients with pulmonary arterial hypertension that is primary or autoimmune and related to congenital heart diseaseSildenafil versus nitric oxide for acute vasodilator testing in pulmonary arterial hypertension.Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.Pulmonary hypertension in bronchopulmonary dysplasiaResponse to bosentan in children with pulmonary hypertension.Advances in pediatric pulmonary arterial hypertension.Use of myocardial performance index in pediatric patients with idiopathic pulmonary arterial hypertension.Epoprostenol treatment in children with severe pulmonary hypertension.A review of pulmonary arterial hypertension: role of ambrisentan.Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment.A New Era in Medical Management of Severe Pediatric Pulmonary Arterial Hypertension.Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan.Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in Cardiac Critical Care Pulmonary Hypertension.
P2860
Q26996078-A57A357E-5DCE-4852-BF89-B8D05FB63D90Q27022763-61766984-03F4-497A-B398-DA8CBF46B657Q27687320-5068497E-2A10-464A-A804-EF1056C738DDQ28085572-3C281118-E99B-4061-97B1-B23CA3D8FCD5Q28346468-9353DB0A-26B2-4065-AC57-3CFE151E5BA4Q30248871-7089713E-898F-44F0-ACAE-E844DCD4D141Q30251927-14625DEC-423A-40D7-AA7E-3A903477594CQ30429733-A1A2F647-A11F-4C55-89F3-ED8EEE7AD124Q30868378-FEF4D90C-8328-49C8-B57F-3EB3FEB590FEQ33154476-ACFB93CD-AC56-4B1E-B333-0CA15128D32FQ33163446-3ADCF3DF-A6DD-46EF-8F7B-7104AEB1EA2CQ33806197-AECEC9EB-DDFD-43ED-A497-4FF53E3E3160Q33965872-68A46627-E25E-4692-82FD-089324BDB2D1Q34027507-96883937-49CA-4253-ADA0-C105740EC1F0Q34232006-A6317440-6510-438F-B993-5B2C4B70EA43Q34798669-F2731068-9DA6-4A4C-B552-B973837A1E8BQ35050464-8934EE76-C317-4C78-AB41-23BB49BD54B9Q35053507-B2BF87BB-DB22-445E-B477-393E3F24A75AQ35079604-3BF0066E-EE0D-4488-ABCF-A3B49E126397Q35110720-DC06BF12-8B66-4A3C-8CAD-FE04D2404523Q35165691-BFAB4F70-38DA-4F6D-9562-5BDAE882AFE6Q35280612-77662159-FB10-4F2F-A890-DD9620AB8E2EQ35375640-E505B146-0EC4-4BDC-80FA-26FE85B6107AQ35566916-DCA627B0-49EE-4BCA-84AB-17CB36FFE54EQ35578998-7E506418-9B21-4B93-AAE2-4BDC26690DC2Q35581586-6D54A3BA-DE01-465F-A473-97D65E6BD4A7Q35665744-889BC352-0AD3-44E1-A4AF-DD156FF1FE2FQ35665767-90E99ED3-6D7F-440E-895D-E590A220C3ACQ35731631-728EFEEA-B9C2-4076-97F4-37528FEFEB34Q35771679-53C6C90E-D5B8-43CE-A9A2-B4D427ADE318Q35869437-7F190485-7E1B-450A-8609-40C1692BAAB1Q35916971-B768F86C-918D-4E4E-87F3-C22E678AFAADQ35954745-9182F444-5305-460E-A3A2-B3AB92ED533CQ36013161-CB8133B4-2A75-41B5-8BBC-F5DD9197264BQ36411653-A8845871-D4C5-48E2-88A0-FE1306714C73Q36481525-C5C3CDE5-C881-4A57-8BD7-43B99357CBA9Q36570843-2413B8E6-BD38-4DFD-919A-655AF0197B08Q36601764-13DF8673-07D6-48E4-822E-6BDA80FAD467Q36718346-8D1F030A-DDD2-4934-B6DD-D24D989534D6Q36763080-4E7D9750-CFEC-4177-9AEB-FD9D62973A2B
P2860
Vasodilator therapy for primary pulmonary hypertension in children.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Vasodilator therapy for primary pulmonary hypertension in children.
@en
Vasodilator therapy for primary pulmonary hypertension in children.
@nl
type
label
Vasodilator therapy for primary pulmonary hypertension in children.
@en
Vasodilator therapy for primary pulmonary hypertension in children.
@nl
prefLabel
Vasodilator therapy for primary pulmonary hypertension in children.
@en
Vasodilator therapy for primary pulmonary hypertension in children.
@nl
P2093
P356
P1433
P1476
Vasodilator therapy for primary pulmonary hypertension in children.
@en
P2093
P304
P356
10.1161/01.CIR.99.9.1197
P407
P577
1999-03-01T00:00:00Z